Medical News

RSS

Edwards Lifesciences' German Andersen patent for transcatheter valve technology upheld

Edwards Lifesciences Corporation, the world leader in the science of heart valves, announced today that the Federal Patent Court in Munich, Germany, has upheld the validity of Edwards' German Andersen patent for transcatheter valve technology. Edwards succeeded in having CoreValve's invalidity claims dismissed on all grounds.

20 Jan 2010

Finding supports modularity of mind theory

Recognizing faces is an important social skill, but not all of us are equally good at it. Some people are unable to recognize even their closest friends (a condition called prosopagnosia), while others have a near-photographic memory for large numbers of faces.

20 Jan 2010

U.S. gastroenterologists to treat hepatitis C patients with telaprevir

Decision Resources, one of the world's leading research and advisory firms for pharmaceutical and healthcare issues, finds that U.S. gastroenterologists will treat a larger proportion of treatment nonresponder hepatitis C patients with Vertex/Tibotec/Mitsubishi Tanabe's telaprevir than Merck's boceprevir.

20 Jan 2010

Recipients of comprehensive primary care twice as likely to rate healthcare as high-quality

Chronically ill older adults who are closely supported by a nurse-physician primary care team are twice as likely to rate their health care as high-quality than those who receive usual care, according to a study by researchers at the Johns Hopkins Bloomberg School of Public Health.

20 Jan 2010

Depomed plans additional Serada Phase 3 trial for treatment of menopausal hot flashes

Depomed, Inc. announced today it has received guidance from the FDA in formal meeting minutes from a meeting held in December regarding SeradaTM, the company’s extended release gabapentin product candidate for the treatment of menopausal hot flashes. Based on guidance reflected in the meeting minutes, Depomed plans to conduct a single additional pivotal Phase 3 trial evaluating Serada for the treatment of menopausal hot flashes.

20 Jan 2010

Lumigent Technologies closes $3 million round of funding from North Bridge Venture Partners

Lumigent Technologies, Inc., the GRC business apps company, today announced it has capped its success in 2009 by closing a new, $3 million round of funding from North Bridge Venture Partners.

20 Jan 2010

Cook Medical presents latest advancements at ISET 2010 International Symposium on Endovascular Therapy

Signaling its continued commitment to addressing the anatomy of the entire peripheral vasculature and combating disease with targeted diagnostic and interventional devices, Cook Medical is presenting its latest advancements at the ISET 2010 International Symposium on Endovascular Therapy.

20 Jan 2010

Gene variant predisposes humans to develop acute myeloid leukemia, says study

A large international research group led by Dr. Tarik M-r-y, a researcher at the Institut de recherches cliniques de Montr-al (IRCM), has discovered that a variant of the gene "Growth Factor Independence 1" (GFI1) predisposes humans to develop acute myeloid leukemia (AML), a certain subtype of blood cancer.

20 Jan 2010

St. Louis Children's Hospital installs Siemens' SOMATOM Definition AS CT scanner

Recognized as one of the leading pediatric healthcare centers in the United States, St. Louis Children's Hospital in St. Louis is further enhancing its nationally renowned pediatric care program with the installation of a SOMATOM® Definition AS computed tomography (CT) scanner from Siemens Healthcare. The SOMATOM Definition AS is the world's first adaptive scanner, which intelligently adapts, on the fly, to the patient, for aiding in dose protection, as well as adapting to new dimensions and space.

20 Jan 2010

Microbiologists explain why apples are beneficial for health

Why does an apple a day keep the doctor away? New research published in the open access journal BMC Microbiology contributes to our understanding of why eating apples is good for you.

20 Jan 2010

Fast Forward, JDRF announce collaborative partnership with Axxam SpA

Fast Forward, LLC, the commercial drug development arm of the National Multiple Sclerosis Society, and the Juvenile Diabetes Research Foundation (JDRF), the leader in research leading to a cure for type 1 diabetes in the world today announced a collaborative partnership with Axxam SpA -- a leading company in conducting early-stage discovery research programs for the life science industry -- to develop new treatments for two autoimmune diseases, multiple sclerosis (MS) and type 1 diabetes (T1D).

20 Jan 2010

Statins may protect SCD children from pneumococcal infection

New research suggests a family of widely used cholesterol-lowering drugs might help protect individuals from serious illness following bacterial infection, including the pneumococcal infections that pose a deadly threat to those with sickle cell disease.

20 Jan 2010

Dynamic mapping may help in detecting links between diseases and environmental exposures

A team of researchers has developed a dynamic mapping tool to gain a more nuanced view of the links between diseases and environmental exposures. The application of the method is illustrated by a number of examples of associations between environmental exposures and Salmonella infections among people in the US age 65 and over in 2002.

20 Jan 2010

HPV testing could be used as standard method of cervical screening for women, say Italian scientists

Human papillomavirus (HPV) testing could be used as the standard method of cervical screening for women aged 35 years or older, as it seems to prevent more invasive cases of the disease than cytology screening alone, Italian scientists have said.

20 Jan 2010

Republican Brown wins Massachusetts Senate seat

The Boston Globe: "Republican Scott Brown tonight pulled off one of the biggest upsets in Massachusetts political history, defeating Democrat Martha Coakley to become the state's next United States senator and potentially derailing President Obama's hopes for a health care overhaul." The

20 Jan 2010

Bracco Diagnostics implements Datalliance VMI to reduce stockouts and maximize inventory investment

Kimberly Cox, Bracco Diagnostics Director of Supply Chain Operations, said, "Our goal with VMI is to expand the service we offer to our large healthcare customers. By assisting with the inventory replenishment process we will help our customers be more efficient by addressing mutual objectives such as reducing stockouts and maximizing inventory investment.

20 Jan 2010

Alnylam Pharmaceuticals presents data on multiple therapeutic programs at RNAi Symposium

Alnylam Pharmaceuticals, Inc., a leading RNAi therapeutics company, today announced that it presented data from multiple pre-clinical and clinical programs at the “RNA Silencing: Mechanism, Biology, and Application” Keystone Symposium held January 14-19, 2010 in Keystone, Colorado. Alnylam and its collaborators presented data from Alnylam’s therapeutic programs including transthyretin (TTR)-mediated amyloidosis and Huntington’s disease, as well as new data on delivery approaches for the systemic delivery of RNAi therapeutics.

20 Jan 2010

iWorx launches a family of cardiovascular research products

iWorx, a developer of advanced physiology research and teaching tools, has launched a family of cardiovascular research products used to assess cardiac performance and hemodynamics, both in vivo and in vitro.

20 Jan 2010

Sagent Pharmaceuticals introduces pamidronate disodium injection in single-dose vials

Sagent Pharmaceuticals, Inc., a privately held specialty pharmaceutical company, today announced that it has launched pamidronate disodium injection in single-dose vials containing 30 mg per 10 mL and 90 mg per 10 mL. Pamidronate disodium injection, the generic alternative of Novartis Pharmaceutical Company's Aredia®, is a bone resorption inhibitor. The 2008 U.S. market for pamidronate disodium approximated $17 million, according to IMS data.

20 Jan 2010

JDRF and BD join to develop novel insulin delivery products for treatment of type 1 diabetes

The Juvenile Diabetes Research Foundation (JDRF) and BD (Becton, Dickinson and Company) announced today an innovative program aimed at improving the treatment of type 1 diabetes by developing novel insulin delivery products to enhance the use of insulin pumps.

From BD (Becton, Dickinson and Company) 20 Jan 2010

Medical News

Edwards Lifesciences' German Andersen patent for transcatheter valve technology upheld

Finding supports modularity of mind theory

U.S. gastroenterologists to treat hepatitis C patients with telaprevir

Recipients of comprehensive primary care twice as likely to rate healthcare as high-quality

Depomed plans additional Serada Phase 3 trial for treatment of menopausal hot flashes

Lumigent Technologies closes $3 million round of funding from North Bridge Venture Partners

Cook Medical presents latest advancements at ISET 2010 International Symposium on Endovascular Therapy

Gene variant predisposes humans to develop acute myeloid leukemia, says study

St. Louis Children's Hospital installs Siemens' SOMATOM Definition AS CT scanner

Microbiologists explain why apples are beneficial for health

Fast Forward, JDRF announce collaborative partnership with Axxam SpA

Statins may protect SCD children from pneumococcal infection

Dynamic mapping may help in detecting links between diseases and environmental exposures

HPV testing could be used as standard method of cervical screening for women, say Italian scientists

Republican Brown wins Massachusetts Senate seat

Bracco Diagnostics implements Datalliance VMI to reduce stockouts and maximize inventory investment

Alnylam Pharmaceuticals presents data on multiple therapeutic programs at RNAi Symposium

iWorx launches a family of cardiovascular research products

Sagent Pharmaceuticals introduces pamidronate disodium injection in single-dose vials

JDRF and BD join to develop novel insulin delivery products for treatment of type 1 diabetes

Redefining control and consistency in anaerobic microbiome workflows

AI in Healthcare: How generative tools are transforming clinical practice

The future of automation: Machine learning–driven hepatocyte and organoid counting

Latest News